Association of peptidoglycan recognition protein 1 to post-myocardial infarction and periodontal inflammation: A subgroup report from the PAROKRANK (Periodontal Disease and the Relation to Myocardial Infarction) study.
IL-1β
MMP-8
PGLYRP1
TREM-1
myocardial infarction
periodontitis
saliva
Journal
Journal of periodontology
ISSN: 1943-3670
Titre abrégé: J Periodontol
Pays: United States
ID NLM: 8000345
Informations de publication
Date de publication:
09 2022
09 2022
Historique:
revised:
27
01
2022
received:
11
10
2021
accepted:
21
02
2022
pubmed:
29
3
2022
medline:
24
9
2022
entrez:
28
3
2022
Statut:
ppublish
Résumé
Peptidoglycan recognition protein 1 (PGLYRP1) is an antimicrobial and proinflammatory innate immunity protein activated during infections. We aimed to investigate whether PGYLRP1 and associated molecules of the immune response in saliva is a cumulative outcome result of both MI and periodontal inflammation. Two hundred patients with MI and another 200 matched non-MI controls were included. A full-mouthexamination was conducted to assess periodontal inflammation and collection of stimulated saliva was performed 6 to 10 weeks after the first MI. PGLYRP1, triggering receptor expressed on myeloid cells 1 (TREM-1), interleukin-1 beta (IL-1β) were analyzed by ELISA. Matrix metalloproteinase (MMP)-8 levels were determined by IFMA. Compared to controls, MI patients showed higher salivary PGLYRP1, but not TREM-1 levels. The difference in PGLYRP1 levels remained after adjustment for covariates. In MI patients, the PGLYRP1 levels positively correlated with BOP and PPD 4 to 5 mm. Among non-MI subjects, the levels of PGLYRP1 correlated positively and significantly with BOP and total PPD. Salivary PGLYRP1 concentrations also showed strong positive correlations with levels of TREM-1, IL-1β and MMP-8. In multivariate linear regression analysis, in MI patients, BOP and former smokingstatus displayed an association with salivary PGLYRP1 concentration. MI patients showed higher salivary PGLYRP1 levels than healthy controls, also after adjusting for smoking, sex, age and periodontal health status. Salivary levels of PGLYRP1 may reflect the overall inflammatory burden to chronic bacterial exposure, possibly underpinning the observed associations between periodontitis and exposure with MI.
Sections du résumé
BACKGROUND
Peptidoglycan recognition protein 1 (PGLYRP1) is an antimicrobial and proinflammatory innate immunity protein activated during infections. We aimed to investigate whether PGYLRP1 and associated molecules of the immune response in saliva is a cumulative outcome result of both MI and periodontal inflammation.
METHODS AND RESULTS
Two hundred patients with MI and another 200 matched non-MI controls were included. A full-mouthexamination was conducted to assess periodontal inflammation and collection of stimulated saliva was performed 6 to 10 weeks after the first MI. PGLYRP1, triggering receptor expressed on myeloid cells 1 (TREM-1), interleukin-1 beta (IL-1β) were analyzed by ELISA. Matrix metalloproteinase (MMP)-8 levels were determined by IFMA. Compared to controls, MI patients showed higher salivary PGLYRP1, but not TREM-1 levels. The difference in PGLYRP1 levels remained after adjustment for covariates. In MI patients, the PGLYRP1 levels positively correlated with BOP and PPD 4 to 5 mm. Among non-MI subjects, the levels of PGLYRP1 correlated positively and significantly with BOP and total PPD. Salivary PGLYRP1 concentrations also showed strong positive correlations with levels of TREM-1, IL-1β and MMP-8. In multivariate linear regression analysis, in MI patients, BOP and former smokingstatus displayed an association with salivary PGLYRP1 concentration.
CONCLUSION
MI patients showed higher salivary PGLYRP1 levels than healthy controls, also after adjusting for smoking, sex, age and periodontal health status. Salivary levels of PGLYRP1 may reflect the overall inflammatory burden to chronic bacterial exposure, possibly underpinning the observed associations between periodontitis and exposure with MI.
Identifiants
pubmed: 35344208
doi: 10.1002/JPER.21-0595
pmc: PMC9796725
doi:
Substances chimiques
Biomarkers
0
Carrier Proteins
0
Interleukin-1beta
0
Triggering Receptor Expressed on Myeloid Cells-1
0
peptidoglycan recognition protein
0
Matrix Metalloproteinase 8
EC 3.4.24.34
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1325-1335Informations de copyright
© 2022 The Authors. Journal of Periodontology published by Wiley Periodicals LLC on behalf of American Academy of Periodontology.
Références
Transplant Proc. 2020 Dec;52(10):3231-3235
pubmed: 32768288
J Am Heart Assoc. 2018 Jun 9;7(12):
pubmed: 29886421
Sci Rep. 2020 Oct 1;10(1):16299
pubmed: 33004892
Circulation. 2016 Feb 9;133(6):576-83
pubmed: 26762521
Eur Heart J. 2021 Jan 1;42(1):113-131
pubmed: 32176778
Nat Commun. 2016 Oct 20;7:13151
pubmed: 27762264
Oral Dis. 2020 Jul;26(5):1045-1052
pubmed: 32026534
Mol Immunol. 2011 Oct;49(1-2):387-94
pubmed: 21967868
J Clin Periodontol. 2000 Jul;27(7):453-65
pubmed: 10914885
Circulation. 2012 May 22;125(20):2520-44
pubmed: 22514251
Oncotarget. 2015 May 30;6(15):12970-83
pubmed: 26025919
Am Heart J. 2006 May;151(5):977-84
pubmed: 16644317
J Clin Periodontol. 2020 Mar;47(3):268-288
pubmed: 32011025
Pharmacol Ther. 2017 Sep;177:81-95
pubmed: 28245991
J Biol Chem. 2010 Oct 22;285(43):33338-33347
pubmed: 20702417
Lancet. 2007 Oct 20;370(9596):1453-7
pubmed: 18064739
Nat Immunol. 2019 Aug;20(8):1023-1034
pubmed: 31263278
J Immunol. 2007 Sep 15;179(6):4065-73
pubmed: 17785845
J Immunol. 2015 Feb 15;194(4):1417-21
pubmed: 25595774
JDR Clin Trans Res. 2020 Oct;5(4):332-341
pubmed: 31860804
J Periodontol. 2020 Oct;91(10):1339-1347
pubmed: 32100289
J Periodontol. 2022 Sep;93(9):1325-1335
pubmed: 35344208
Atherosclerosis. 2007 Feb;190(2):271-81
pubmed: 16620832
Am Heart J. 2013 Apr;165(4):609-14
pubmed: 23537979
J Periodontol. 2000 Oct;71(10):1554-60
pubmed: 11063387
J Clin Med. 2019 Oct 01;8(10):
pubmed: 31581596
Mol Cell Proteomics. 2018 Jul;17(7):1392-1409
pubmed: 29610270
Trends Microbiol. 2007 Mar;15(3):127-34
pubmed: 17275309
Periodontol 2000. 2020 Jun;83(1):90-106
pubmed: 32385879
JDR Clin Trans Res. 2019 Oct;4(4):352-359
pubmed: 31013451
Clin Med Res. 2004 Aug;2(3):181-7
pubmed: 15931355
Eur Heart J. 2012 Oct;33(20):2551-67
pubmed: 22922414
Atherosclerosis. 2009 Apr;203(2):569-75
pubmed: 18774573
J Clin Periodontol. 2017 Jul;44(7):692-699
pubmed: 28453865
Pharmacol Res. 2015 Oct;100:261-5
pubmed: 26318764
J Periodontol. 2018 Jan;89(1):117-129
pubmed: 28846062
Circ Res. 2015 May 22;116(11):1772-82
pubmed: 25840803
J Intern Med. 2020 Mar;287(3):301-309
pubmed: 31633250
Am J Cardiol. 2002 Jul 15;90(2):119-23
pubmed: 12106839
PLoS One. 2015 Jul 01;10(7):e0126370
pubmed: 26132583
Clin Exp Immunol. 2014 Oct;178(1):190-200
pubmed: 24924298
J Clin Periodontol. 2012 Dec;39(12):1141-8
pubmed: 23067264
Circulation. 2001 Oct 16;104(16):1899-904
pubmed: 11602491
J Clin Periodontol. 2020 Jul;47 Suppl 22:199-238
pubmed: 31834951
J Dent Res. 2013 Feb;92(2):161-5
pubmed: 23242230
Innate Immun. 2010 Jun;16(3):168-74
pubmed: 20418257
J Am Coll Cardiol. 2016 May 17;67(19):2310-2312
pubmed: 27173041
Blood. 2003 Jul 15;102(2):689-97
pubmed: 12649138
Ann Med. 2006;38(5):306-21
pubmed: 16938801
FEMS Immunol Med Microbiol. 2012 Oct;66(1):37-44
pubmed: 22540741